These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32423348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial.
    Juraschek SP, Kovell LC, Appel LJ, Miller ER, Sacks FM, Chang AR, Christenson RH, Rebuck H, Mukamal KJ.
    J Am Coll Cardiol; 2021 Jun 01; 77(21):2625-2634. PubMed ID: 34045018
    [Abstract] [Full Text] [Related]

  • 3. Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH-Sodium Trial.
    Belanger MJ, Kovell LC, Turkson-Ocran RA, Mukamal KJ, Liu X, Appel LJ, Miller ER, Sacks FM, Christenson RH, Rebuck H, Chang AR, Juraschek SP.
    J Am Heart Assoc; 2023 Jan 17; 12(2):e026684. PubMed ID: 36628985
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
    Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.
    Am J Kidney Dis; 2014 Sep 17; 64(3):443-51. PubMed ID: 24787760
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 17; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Associations of Ambulatory Blood Pressure Measurements With High-Sensitivity Troponin and Natriuretic Peptide Levels in SPRINT.
    Venishetty N, Berry JD, de Lemos JA, Wu E, Lee M, Drawz PE, Nambi V, Ballantyne CM, Killeen AA, Ix JH, Shlipak MG, Ascher SB.
    Am J Hypertens; 2024 Jul 15; 37(8):571-579. PubMed ID: 38554284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H, Fan WZ, Wang SC, Liu ZH, Zang HL, Wang LZ, Liu HJ, Shen XH, Liang SQ.
    J Crit Care; 2015 Jun 15; 30(3):654.e9-14. PubMed ID: 25575850
    [Abstract] [Full Text] [Related]

  • 11. Relation of Dietary Sodium Intake With Subclinical Markers of Cardiovascular Disease (from MESA).
    Kapoor K, Fashanu O, Post WS, Lutsey PL, Michos ED, deFilippi CR, McEvoy JW.
    Am J Cardiol; 2019 Aug 15; 124(4):636-643. PubMed ID: 31300201
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M.
    Am Heart J; 2010 Jan 15; 159(1):63-7. PubMed ID: 20102868
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.
    Juraschek SP, Wang D, McEvoy JW, Harrap S, Harris K, Mancia G, Marre M, Neal B, Patel A, Poulter NR, Williams B, Chalmers J, Woodward M, Selvin E.
    Int J Cardiol; 2022 Jul 01; 358():103-109. PubMed ID: 35439582
    [Abstract] [Full Text] [Related]

  • 16. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T.
    Heart Vessels; 2019 Mar 01; 34(3):410-418. PubMed ID: 30229410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD, Nambi V, Ambrosius WT, Chen H, Killeen AA, Taylor A, Toto RD, Soliman EZ, McEvoy JW, Pandey A, Joshi PH, Blankenberg S, Kitzman DW, Ballantyne CM, de Lemos JA.
    JAMA Cardiol; 2021 Dec 01; 6(12):1397-1405. PubMed ID: 34468696
    [Abstract] [Full Text] [Related]

  • 19. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J, CLARICOR Trial Group.
    Scand J Clin Lab Invest; 2011 Feb 01; 71(1):52-62. PubMed ID: 21108561
    [Abstract] [Full Text] [Related]

  • 20. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
    Eggers KM, Lindahl B, Venge P, Lind L.
    Int J Cardiol; 2018 Apr 15; 257():300-305. PubMed ID: 29506712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.